Literature DB >> 11443561

Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum.

S Günther1, B Weisner, A Roth, T Grewing, M Asper, C Drosten, P Emmerich, J Petersen, M Wilczek, H Schmitz.   

Abstract

The pathogenesis of neurologic complications of Lassa fever is poorly understood. A Nigerian patient had fever, disorientation, seizures, and blood-brain barrier dysfunction, and Lassa virus was found in cerebrospinal fluid (CSF) but not in serum. The concentration of Lassa virus RNA in CSF corresponded to 1 x 10(3) pfu/mL, as determined by a quantitative real-time polymerase chain reaction assay. To characterize the Lassa virus in CSF, the 3.5-kb S RNA was sequenced. In the S RNA coding sequences, the CSF strain differed between 20% and 24.6% from all known prototype strains. These data suggest that Lassa virus or specific Lassa virus strains can persist in the central nervous system and thus contribute to neuropathogenesis. Lassa virus infection should be considered in West African patients or in travelers returning from this area who present only with fever and neurologic signs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443561     DOI: 10.1086/322033

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA.

Authors:  Stephan Olschläger; Michaela Lelke; Petra Emmerich; Marcus Panning; Christian Drosten; Meike Hass; Danny Asogun; Deborah Ehichioya; Sunday Omilabu; Stephan Günther
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

2.  Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus.

Authors:  Stefanie Müller; Stephan Günther
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

Review 3.  Laboratory Diagnosis of Lassa Fever.

Authors:  Vanessa Raabe; Jeffrey Koehler
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

4.  Design of peptide-based epitope vaccine and further binding site scrutiny led to groundswell in drug discovery against Lassa virus.

Authors:  Mohammad Uzzal Hossain; Taimur Md Omar; Arafat Rahman Oany; K M Kaderi Kibria; Abu Zaffar Shibly; Md Moniruzzaman; Syed Raju Ali; Md Monirul Islam
Journal:  3 Biotech       Date:  2018-01-16       Impact factor: 2.406

5.  Early-onset sensorineural hearing loss in Lassa fever.

Authors:  T S Ibekwe; P O Okokhere; D Asogun; F F Blackie; M M Nwegbu; K W Wahab; S A Omilabu; G O Akpede
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-01       Impact factor: 2.503

6.  Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination.

Authors:  Anura Rambukkana; Stefan Kunz; Jenny Min; Kevin P Campbell; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus.

Authors:  Marcel Asper; Thomas Sternsdorf; Meike Hass; Christian Drosten; Antje Rhode; Herbert Schmitz; Stephan Günther
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.

Authors:  Christian Drosten; Stephan Göttig; Stefan Schilling; Marcel Asper; Marcus Panning; Herbert Schmitz; Stephan Günther
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

9.  Pathogenesis of Lassa fever in cynomolgus macaques.

Authors:  Lisa E Hensley; Mark A Smith; Joan B Geisbert; Elizabeth A Fritz; Kathleen M Daddario-DiCaprio; Tom Larsen; Thomas W Geisbert
Journal:  Virol J       Date:  2011-05-06       Impact factor: 4.099

10.  The sensitivity and specificity of Lassa virus IgM by ELISA as screening tool at early phase of Lassa fever infection.

Authors:  Titus S Ibekwe; Maxwell M Nwegbu; Daniel Asogun; Donatus I Adomeh; Peter O Okokhere
Journal:  Niger Med J       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.